Results 41 to 50 of about 51,717 (226)

Cutaneous Aspergilosis Caused by Aspergillus Flavus: A Case Report

open access: yesBerkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology), 2021
Background: Cutaneous aspergillosis occurs relatively less frequent and therefore remains poorly characterized. Cutaneous aspergillosis can be as primary or secondary infection.
Maria Ulfa Sheilaadji   +4 more
doaj   +1 more source

Disseminated Aspergillosis due to Aspergillus niger in Immunocompetent Patient: A Case Report

open access: yesCase Reports in Infectious Diseases, 2013
Invasive aspergillosis is a major cause of morbidity and mortality in immunocompromised patients. Many cases of pulmonary, cutaneous, cerebral, and paranasal sinus aspergillosis in immunocompetent patient were defined in literature but disseminated ...
Ulku Ergene   +4 more
doaj   +1 more source

Effect of laminar air flow and building construction on aspergillosis in acute leukemia patients: a retrospective cohort study

open access: yesBMC Infectious Diseases, 2019
Background The preventive effect of laminar air flow (LAF) on aspergillosis has been observed in patients with hematological malignancies. However, the short follow-up period limits the interpretation of study results.
Makoto Iwasaki   +6 more
doaj   +1 more source

Epidemiology of Aspergillosis in Cancer Patients in Taiwan

open access: yesInfection and Drug Resistance, 2022
Chien-An Chen,1,2,* Chung-Han Ho,3– 5,* Yu-Cih Wu,3 Yi-Chen Chen,3 Jhi-Joung Wang,3 Kuang-Ming Liao6 1Division of Hepatogastroenterology, Department of Internal Medicine, Chi Mei Medical Center, Tainan, 71004, Taiwan; 2Division of Hospital ...
Chen CA   +5 more
doaj  

Invasive fungal infection by Aspergillus flavus in immunocompetent hosts: A case series and literature review

open access: yesMedical Mycology Case Reports, 2019
Invasive aspergillosis usually affects immunocompromised hosts with variable manifestations depending on the site of infection. In this article, we present two cases of invasive Aspergillosis in two non-immunocompromised patients; both cases had a ...
Ana María Garcia-Giraldo   +4 more
doaj   +1 more source

Influenza associated pulmonary aspergillosis in california: A case series

open access: yesClinical Infection in Practice, 2022
Introduction: Invasive pulmonary aspergillosis has been reported to occur in patients who are critically ill with severe influenza. The mortality rate is high.
John Z. Deng   +8 more
doaj   +1 more source

Immunotherapy of aspergillosis [PDF]

open access: yesClinical Microbiology and Infection, 2012
Management of invasive aspergillosis in high-risk patients remains challenging. There is an increasing demand for novel therapeutic strategies aimed at enhancing or restoring antifungal immunity in immunocompromised patients. In this regard, modulation of specific innate immune functions and vaccination are promising immunotherapeutic strategies ...
Carvalho A.   +3 more
openaire   +4 more sources

Diagnostic Delay in Eosinophilic Granulomatosis With Polyangiitis: Clinical Predictors and Implications for Earlier Recognition

open access: yesAllergy, EarlyView.
This study aimed to assess diagnostic delay among patients with eosinophilic granulomatosis with polyangiitis (EGPA) and identify clinical characteristics associated with delayed recognition. EGPA diagnosis was delayed by nearly five years from symptom onset in this single‐center cohort.
Vani Mulkareddy   +9 more
wiley   +1 more source

Pulmonary Aspergillosis in Patients with Cystic Fibrosis in Russian Federation

open access: yesЖурнал инфектологии, 2018
The aim: to assess the incidence of various forms of pulmonary aspergillosis in patients with cystic fibrosis.Materials and methods. In 2014-2017 yy. in prospective study in  different regions of Russia were included 190 patients with cystic  fibrosis ...
Ya. I. Kozlova   +11 more
doaj   +1 more source

Preventing infections after CD19‐directed chimeric antigen receptor T‐cell therapies for lymphoma: a consensus practice statement

open access: yesInternal Medicine Journal, EarlyView.
Abstract Chimeric antigen receptor (CAR) T‐cell therapies directed against cluster of differentiation 19 (CD19) are a standard of care for relapsed or refractory B‐cell lymphomas. Infection is the leading cause of non‐relapse mortality, and this risk may persist for years after CAR T‐cell receipt.
Aine Hurley   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy